Advisor Group Holdings, Inc. Puma Biotechnology, Inc. Transaction History
Advisor Group Holdings, Inc.
- $52.6 Billion
- Q2 2025
A detailed history of Advisor Group Holdings, Inc. transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 17,944 shares of PBYI stock, worth $88,284. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,944
Previous 14,850
20.84%
Holding current value
$88,284
Previous $50,000
22.0%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding PBYI
# of Institutions
126Shares Held
33.6MCall Options Held
68.2KPut Options Held
0-
Acorn Capital Advisors, LLC New York, NY4.13MShares$20.3 Million9.27% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.71MShares$18.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.57MShares$17.6 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA2.01MShares$9.88 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.87MShares$9.22 Million0.01% of portfolio
About PUMA BIOTECHNOLOGY, INC.
- Ticker PBYI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,556,000
- Market Cap $224M
- Description
- Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...